Amanda M Brandow, DO

Milwaukee Campus-Children's Wisconsin

8915 W. Connell Court

Milwaukee, WI 53226

Clinic phone: (414) 266-2421

Services

Dr. Brandow is a board certified pediatric hematologist/oncologist. She has a special interest in providing comprehensive and compassionate care for children with sickle cell disease and other hemoglobinopathies in addition to other hematologic diseases including children with anemia, thrombocytopenia and neutropenia. Dr. Brandow is specifically interested in developing better ways to assess and treat pain in children with sickle cell disease. She is committed to and enjoys teaching medical students, residents, and fellows to help them learn to provide comprehensive and compassionate care to their patients.

Certifications

Pediatric Hematology-Oncology, Pediatrics

Areas of Interest

Hematology
Sickle cell disease
BMT for sickle cell disease
Sickle cell disease neuropsychological complications
Sickle cell disease new therapeutic agents
Thalassemia

Education

2001, Midwestern University (Downers Grove, IL), DO

Residencies

2004, Medical College of Wisconsin - Pediatrics
2005, Medical College of Wisconsin - Pediatrics

Fellowships

2008, Medical College of Wisconsin - Ped Hem/Onc

Awards

Milwaukee Top Doctors
Outstanding Medical Student Teacher (Medical College of Wisconsin)
Best Doctors in America

Research

Dr. Brandow’s research is focused on investigating the underlying reasons that individuals with sickle cell disease experience pain. Through this research she hopes to develop new pain treatments for both children with sickle cell disease. Dr. Brandow also studies ways to better assess pain in children with sickle cell disease and the outcomes of pain treatment in these children.

Grants

Peripheral Sensitization as a Novel Mechanism for Pain in Sickle Cell Disease
NIH Loan Repayment Program in Pediatric Research
Principal Investigator
Quantitative Assessment of Neuropathic Pain in Pediatric Oncology Patients Treated with Vincristine
Midwest Athletes Against Childhood Cancer (MACC Fund)
Principle Investigator
Pharmacokinetics and Relative Bioavailability of a Liquid Formulation of Hydroxyurea in Pediatric Patients with Sickle Cell Anemia
NIH/NICHD; NIH subcontract
Site Principal Investigator

Publications

Sadler KE, Atkinson SN, Ehlers VL, Waltz TB, Hayward M, Rodríguez García DM, Salzman NH, Stucky CL, Brandow AM. Gut microbiota and metabolites drive chronic sickle cell disease pain. bioRxiv. 2023 Apr 28 PMID: 37163080 PMCID: PMC10168372 05/10/2023

Mucalo L, Field JJ, Highland J, Khan H, Hankins JS, Singh A, Brandow AM. Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease. Blood Adv. 2023 Jul 25;7(14):3658-3665 PMID: 37058480 PMCID: PMC10365933 SCOPUS ID: 2-s2.0-85183192690 04/15/2023

Allison RL, Burand A, Torres DN, Brandow AM, Stucky CL, Ebert AD. Sickle cell disease patient plasma sensitizes iPSC-derived sensory neurons from sickle cell disease patients. bioRxiv. 2023 Jan 10 PMID: 36711992 PMCID: PMC9882050 01/31/2023

Singh A, Dasgupta M, Retherford D, Baker M, Hulihan M, Brandow AM. Surveillance for the Rare Condition of Sickle Cell Disease in Wisconsin. WMJ. 2022 Dec;121(4):297-300 PMID: 36637841 PMCID: PMC10026077 SCOPUS ID: 2-s2.0-85146364141 01/14/2023

Mucalo L, Brandow AM, Singh A. A perspective on the sickle cell disease international COVID-19 registry. Best Pract Res Clin Haematol. 2022 Sep;35(3):101385 PMID: 36494148 PMCID: PMC9509018 SCOPUS ID: 2-s2.0-85140073334 12/10/2022

Carroll CP, Brandow AM. Chronic Pain: Prevalence and Management. Hematol Oncol Clin North Am. 2022 Dec;36(6):1151-1165 PMID: 36400536 SCOPUS ID: 2-s2.0-85141978813 11/19/2022

Singh A, Brandow AM, Wun T, Shet AS. COVID-19 and venous thromboembolism risk in patients with sickle cell disease. Blood Adv. 2022 Aug 09;6(15):4408-4412 PMID: 35763429 PMCID: PMC9239700 SCOPUS ID: 2-s2.0-85135470847 06/29/2022

Strouse JJ, Brandow AM. Web Exclusive. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Acute Pain Episodes in Sickle Cell Disease. Ann Intern Med. 2022 Mar;175(3):HO2-HO3 PMID: 35286823 SCOPUS ID: 2-s2.0-85126699842 03/15/2022

Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol. 2022 Mar 03;15(1):20 PMID: 35241123 PMCID: PMC8895633 SCOPUS ID: 2-s2.0-85125690529 03/05/2022

Curtis SA, Raisa BM, Roberts JD, Hendrickson JE, Starrels J, Lesley D, Michelle D, Daniel Z, Brandow AM. Non-crisis related pain occurs in adult patients with sickle cell disease despite chronic red blood cell exchange transfusion therapy. Transfus Apher Sci. 2022 Apr;61(2):103304 PMID: 34782244 PMCID: PMC9838733 SCOPUS ID: 2-s2.0-85119079115 11/17/2021

Publications of Amanda Brandow DO from the Faculty Collaboration Database

Why no ratings

Locations

Overview